U.S. Bancorp USB has been analyzed by 13 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 6 | 5 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 4 | 4 | 0 | 0 |
2M Ago | 2 | 1 | 1 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated U.S. Bancorp and provided 12-month price targets. The average target is $48.65, accompanied by a high estimate of $55.00 and a low estimate of $43.00. This current average represents a 1.8% decrease from the previous average price target of $49.54.
Investigating Analyst Ratings: An Elaborate Study
The standing of U.S. Bancorp among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Vivek Juneja | JP Morgan | Lowers | Overweight | $43.50 | $45.00 |
Erika Najarian | UBS | Lowers | Neutral | $43.00 | $47.00 |
Peter Winter | DA Davidson | Lowers | Neutral | $44.00 | $45.00 |
Mike Mayo | Wells Fargo | Lowers | Overweight | $48.00 | $50.00 |
Jason Goldberg | Barclays | Lowers | Overweight | $52.00 | $56.00 |
David Konrad | Keefe, Bruyette & Woods | Lowers | Market Perform | $45.00 | $52.00 |
Chris Kotowski | Oppenheimer | Lowers | Outperform | $54.00 | $55.00 |
Ken Usdin | Jefferies | Raises | Hold | $46.00 | $44.00 |
David Konrad | Keefe, Bruyette & Woods | Raises | Outperform | $52.00 | $50.00 |
Vijay Kumar | Evercore ISI Group | Raises | In-Line | $48.00 | $46.00 |
Saul Martinez | HSBC | Raises | Buy | $53.00 | $47.00 |
David Rochester | Compass Point | Raises | Buy | $49.00 | $46.00 |
Chris Kotowski | Oppenheimer | Lowers | Outperform | $55.00 | $61.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to U.S. Bancorp. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of U.S. Bancorp compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for U.S. Bancorp's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of U.S. Bancorp's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on U.S. Bancorp analyst ratings.
Discovering U.S. Bancorp: A Closer Look
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in roughly 26 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Understanding the Numbers: U.S. Bancorp's Finances
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, U.S. Bancorp faced challenges, resulting in a decline of approximately -0.68% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: U.S. Bancorp's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 18.09%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.49%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): U.S. Bancorp's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.18%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: U.S. Bancorp's debt-to-equity ratio is below the industry average. With a ratio of 1.43, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: What Are They?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.